A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective

INTRODUCTION: Smoking drives substantial direct health care spending, comprising 8.7% ($168 billion) of annual United States aggregated spending. Smoking cessation (SC) prescription use is an effective strategy to improve health outcomes, increase quit rates, and reduce economic burden. However, pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Christine L, Ding, Yao, Ferrufino, Cheryl P, Kowal, Stacey, Tan, Jenen, Subedi, Prasun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/
https://www.ncbi.nlm.nih.gov/pubmed/30038510
http://dx.doi.org/10.2147/CEOR.S165576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052927/
https://www.ncbi.nlm.nih.gov/pubmed/30038510
http://dx.doi.org/10.2147/CEOR.S165576

Ejemplares similares